News & Media: All

Nov 24, 2015

Precision's Jena to Participate in Upcoming AEI Forum

Precision's Principal Consultant Anupam Jena has been invited by the AEI to participate in a upcoming forum: "Rethinking the storyline for defensive medicine and medical liability: Causes, effects, and remedies."  The forum will be held on December 2nd, 2015 from 3:30-5:00pm ET at the AEI in Was ...

Nov 23, 2015

Precision's Karen Becker Quoted in Roll Call

Precision for Medicine’s Karen Becker has been quoted in the latest edition of Roll Call, as Congress considers regulation of Lab-Developed Tests.

Here is the complete article:

Roll Call

November 20, 2015

Congress Considers Regulation of Lab-Developed Tests

By Andrew Siddons

As the Food ...

Nov 18, 2015

Goldman in Modern Healthcare: Drop Medicaid 'Best Price' Rules

In the latest edition of Modern Healthcare, Precision's Dana Goldman addresses Medicare's "best price" drug rules, suggesting a value-based strategy.

To read Dr. Goldman's complete commentary, please click here.

Nov 17, 2015

Philipson Quoted in Bloomberg BNA's Health Care Policy Report

Precision's Tomas Philipson was quoted in the just-released Bloomberg BNA Health Care Policy Report. Also look for Precision Scientific Advisor Seth Seabury's contributions to the report.

To read the complete report, please click the following link: Study Says More Doctor Spending Linked to Few ...

Nov 4, 2015

Precision for Value Acquires Redwood Outcomes

Extends Leadership and Global Reach in Health Economics and Outcomes Research

Gladstone, N.J. and Vancouver, B.C., November 4, 2015 – Precision for Value (Precision) today announced that it has acquired Redwood Outcomes, a leading international health economics and outcomes research (HEOR) ...

Nov 3, 2015

Philipson in Forbes: Myths and Facts About Specialty Drugs

Along with co-authors Dana Goldman and Anupam Jena, Tomas Philipson's latest op-ed examines some common myths about specialty drugs.

To read the complete article, please click here.

Oct 27, 2015

Precision's Tomas Philipson Advocates for Advancement of Drug Development In New York Times

Precision Health Economics founding partner Tomas Philipson has joined a prestigious group advocating for the advancement of drug development. In association with the Manhattan Institute, Dr. Philipson's endorsement has been included in a full-page ad that recently ran in the New York Times.

T ...

Oct 8, 2015

Chandra and Goldman in Harvard Business Review

Precision's Chief Scientific Officer Amitabh Chandra and PHE founding partner Dana Goldman address health care's Short-Termism problem in their latest article for the Harvard Business Review.

To view the complete article, please click here.

Oct 7, 2015

Philipson in Forbes: Do We Want Centralized or Decentralized Medicine?

In Tomas Philipson's latest Op-Ed, he addresses "step therapy" and centralized vs. decentralized medicine.

To read the complete commentary, please click here.

Oct, 2015

Goldman & Lakdawalla in Health Affairs Blog: "Moving Beyond Pay-Per-Dose"

Precision Health Economics founding partners Dana Goldman and Darius Lakdawalla address the need to evolve beyond price-per-dose in the pharmaceutical industry in their latest Health Affairs blog post.

To read the complete article, please click here.

Sep 30, 2015

Precision's Goldman and Lakdawalla Participate in "Future of Specialty Drugs" DC Conference

Precision Health Economics founding partners Dana Goldman and Darius Lakdawalla participated in a conference on Thursday, Oct. 1st, focusing on the future of specialty drugs. The conference, co-sponsored by USC's Schaeffer Center, The Hill, and Amgen took place at The Newseum in Washington, DC. ...

Sep 29, 2015

Philipson Addresses Innovation in Celgene Newsroom Article

Precision Health Economics founding partner Tomas Philipson was quoted on the topic of medical innovation in an article appearing in the Celgene Newsroom. To read the complete article, please click here.

Sep 24, 2015

Precision's Lakdawalla Weighs In On Drug Pricing Controls in New York Times

Precision Health Economics founding partner Darius Lakdawalla weighs in on drug pricing controls in this week's New York Times Opinion feature, "Room for Debate."

To read the complete article, please click here.

Sep 4, 2015

Tomas Philipson In Forbes: "World Returns In Health Care Will Drive How Long You Live, But Your Country Will Stand In Your Way"

Tomas Philipson's latest Op-Ed examines how international linkages between health care economies will affect how long you and your kids will live.

To read the complete commentary, please click here.

Aug 26, 2015

Precision Digital Trends Survey: What Payers Want From Pharma Can Vary

New York, August 26, 2015 – Precision Advisors (, a Precision for Value company, today announced additional findings from its 2015 Digital Trends Study of managed care executives on the types of information Managed Care Organizations (MCOs) requested and received fro ...

Aug 19, 2015

Precision's MacEwan Participates in NEHI "On Call" Series

The Network for Excellence in Health Innovation (NEHI) held a special forum on August 19th, focusing on better use of medicines in diabetes, featuring the recent study and ADA presentation by Precision's Joanna MacEwan.

Dr. MacEwan discussed her recent work and fielded questions from the NEHI ...

Aug 10, 2015

Philipson in Forbes: "Dying to Live"

Tomas Philipson's latest Op-Ed examines end of life care, and why health care is so valuable in the face of death.

To read the complete article, please click here.

Jul 23, 2015

Precision in Bioprocess Online

Precision’s Deb Phippard, PhD, and Jared Kohler, PhD, address the potential of Big Data, analytics, and technology to increase efficiency and decrease costs in the drug development process in a guest column for Bioprocess Online. Read the full article here.

Jul 23, 2015

Precision's Renick and Blandford in Value Based Cancer Care Magazine

Precision’s Dan Renick and Larry Blandford discuss the implications of the new provider-driven value assessment tools in oncology in the July issue of Value Based Cancer Care magazine. Read more here.

Jul 9, 2015

Philipson in Forbes: California's Vaccination Mandate

Tomas Philipson's latest Op-Ed examines California's recently enacted vaccination mandate, and the application of economic epidemiology.

To read his column, please click here.

Jul 6, 2015

Precision's Ton Teaches NIH Course

Precision Associate Director and Senior Research Epidemiologist Thanh Ton has been selected by the National Institutes of Health to teach data management and analysis at the NIH/Fogarty Global Health Program for Scholars and Fellows, to be held July 10-15th in Bethesda, MD. This is Dr. Ton's thi ...

Jul, 2015

PHE's Goldman Elected to ISPOR Board of Directors

Precision is proud to announce that founding partner Dana Goldman has been elected to ISPOR's Board of Directors, effective July 1st, 2015. The Board of Directors are elected by ISPOR members – over 9,500 global members were given the opportunity to vote for nominated candidates.

The Intern ...